DANIEL DEVRIES: Open Payments
NPI 1659937381 · ENGLEWOOD, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,106 in 43 payments from 16 companies in 2025. Trend: 2023 $615 · 2024 $844 · 2025 $1,106
Food & beverage: $1,106
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 10 | $222 |
| Novartis Pharmaceuticals Corporation | 6 | $139 |
| Edwards Lifesciences Corporation | 1 | $126 |
| Medtronic, Inc. | 1 | $108 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $97 |
| PFIZER INC. | 4 | $97 |
| E.R. Squibb & Sons, L.L.C. | 3 | $68 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $59 |
| HEARTFLOW, INC. | 3 | $53 |
| Abbott Laboratories | 1 | $24 |
Products named: REPATHA, LEQVIO, LINQ II, JARDIANCE, VYNDAQEL, Kerendia, FFRct, CAMZYOS.
Industry payments across CO — which companies pay providers there.
